Determinants of survival in HER2+ metastatic esophagogastric cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research（2023）

引用 0|浏览61

暂无评分

摘要

These findings highlight the clinical relevance of identifying baseline intrapatient heterogeneity and serial ctDNA monitoring of HER2-positive EG cancer patients to identify early evidence of treatment resistance, which could guide proactive therapy escalation or de-escalation.

查看译文

关键词

metastatic esophagogastric cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要